Position in MRK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,238,032
+$2,867,100 QoQ
Shares Held
143,304
+5.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $159,480,021 across 17 Drug Manufacturers - General names. MRK ranks #4 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,669 | $46,603,818 | |
| 2 | ABBV |
AbbVie Inc.
|
118,301 | $25,729,278 | |
| 3 | JNJ |
Johnson & Johnson
|
86,066 | $21,037,966 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
143,304 | $17,238,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
74,137 | $10,332,465 | |
| 6 | AMGN |
Amgen Inc
|
29,101 | $10,239,178 | |
| 7 | PFE |
Pfizer Inc
|
258,469 | $7,257,803 | |
| 8 | NVS |
Novartis AG
|
38,689 | $5,909,741 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,238,032 | 143,304 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,370,932 | 136,528 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,909,276 | 118,066 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $9,856,208 | 124,510 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $10,274,373 | 114,465 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,421,691 | 114,814 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,656,730 | 129,066 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,978,366 | 129,066 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $16,126,001 | 122,213 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $13,067,569 | 119,864 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $13,444,132 | 130,589 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,337,864 | 132,922 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $14,785,971 | 138,979 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $14,933,200 | 134,594 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,836,647 | 125,832 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,177,800 | 122,604 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $9,221,513 | 112,389 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $8,585,592 | 112,025 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,412,992 | 112,009 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $7,895,984 | 101,530 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $7,611,249 | 98,732 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $7,341,134 | 89,745 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $7,466,247 | 90,009 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,887,860 | 89,071 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $6,290,532 | 81,759 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||